american diabetes association history of pancreatitis glp-1 receptor agonist Frontiers Frontiers | Glucagon-like peptide-1 receptor
Description
Therefore, it is unclear whether there is an interaction between insulin and GLP-1RA that affects the results
In a twist, the study found that although there was a small increase in diabetic retinopathy, GLP-1 use appeared to protect against the conditions progression and sight-threatening complications
AEDIT founder Dr
Introduction Cardiovascular disease (CVD) is the main cause of morbidity and mortality in patients with type 2 diabetes (T2DM), with a relevant impact on the economic costs for health care systems and on the quality of life for many patients (1, 2)
We estimate that roughly half of people affected by obesity in the US will be eligible to benefit from GLP-1s overall, around 50 million people
Curr Opin Gastroenterol 2017
